A federal judge wiped out approximately 50,000 plaintiffs’ claims that their use of Zantac and its generic derivatives caused them to develop various forms of cancer. In issuing her ruling, U.S. District Judge Robin Rosenberg said that the plaintiffs’ experts could not provide accurate testimony because they “systematically utilized unreliable methodologies” and demonstrated “a lack of internally consistent, objective, science-based standards for the evenhanded evaluation of data.”
Lawyers ...
continue reading...